![](https://investorshub.advfn.com/uicon/486527.png?cb=1571677899)
Tuesday, July 05, 2016 5:21:51 PM
1)It would appear that there is No known/pending issues that clashes with PH3 trials with the FDA despite the posts: It would have happened ALREADY but:This has been Going on for 11 MONTHS!
2) ONLY TWO Biotec savants dealing with the above issue would INVEST and it would NOT be a material position but COULD BE MEANINGFUL to their future portfolio results!
3) CEO LP believes it is sufficient before Bigger News
4) CEO LP apparently chose Charden Capital because of Gbola Amusa, MD, CFA who clearly has the CLOUT both in the US and Europe even with sub $1 stocks to DEAL with NEFARIOUS NETWORK of MANIPULATORS.
5) As for those TWO NEW INST'L Investors: Just take a simple look @ this other issue I own and it should be readily apparent!:
http://www.nasdaq.com/symbol/mstx/institutional-holdings
6) Another reminder one should have already done an extensive Google on Les Goldman to understand what he had achieved in his distinguished career and why he chose to be with NWBO along with providing bridge loans when needed.
Pursuing and doting on what's uncovered from the points above may give one some further clarity beyond their nose.
CROW all you like: getting closer.
Tenacious CEO Linda Powers MOVING ON and going for yet another dip, round tripping from The Ashes to the expected Phoenix.
At this juncture separating the Boys from the Men in this long brutal endeavor.
Was comforted by catching up and uncovering RKMatters clairvoyant discoveries mid May.
Not losing any sleep given my exit and re-entry points.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM